The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.


Updates from The Motley Fool

Latest updates on AstraZeneca from Fool.com.


Stock Performance

AZN vs. S&P 500 | 2 Year Performance
View Interactive AZN Charts
Sponsored by

Key Data Points

Primary metrics and data points about AstraZeneca.
Current Price: $31.54
Prev Close: $30.91
Open: $31.05
Bid: $31.53
Ask: $31.54
Day's Range: $31.04 - $31.57
52wk Range: $26.97 - $34.88
Volume: 9,365,293
Avg Vol 6,735,824
Market Cap: $79.73B
P/E (ttm): 13.86
EPS (ttm): $2.23
Div & Yield: $0.90 (4.4%)

Company Rating

What our community thinks about AstraZeneca.
CAPS Rating 4 out of 5
 
705 Outperform
45 Underperform
CAPS All Stars
 
165 Outperform
8 Underperform

How do you think AstraZeneca will perform against the market?



You pick for AstraZeneca is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Pascal Soriot, CEO

80% Approve

Based on 294 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AstraZeneca.

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers